Truthout
Vaccines
Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID-19
The Trump administration has allowed executives to keep investments in companies profiting from their COVID-19 efforts.
Poorer Countries May Have to Wait Years for a COVID Vaccine
U.S. must act now and leverage its stake in vaccine development to prevent “global vaccine apartheid,” advocates say.
Pfizer CEO Dumped $5.6 Million in Stock on Day of Encouraging Vaccine News
A watchdog group has called for Pfizer and other pharmaceutical companies to freeze the sale of stocks by executives.
Days After Hopeful Pfizer Vaccine News, 82% of Doses Bought by Richest Nations
Mass purchases of the vaccine by the richest countries have left more than 85% of the global population without access.
Consumer Advocates Warn Pfizer Data Is Incomplete — Vaccine Is Still Months Away
Pfizer released promising but preliminary data on a potential COVID-19 vaccine into a charged post-election atmosphere.
Biden Says Vaccine News Is “Great,” But Warns Masks Are Still Needed
Many experts agree that, in a best-case scenario, widespread access to a vaccine won't happen until mid-2021.
“Herd Immunity” Was Originally About Vaccination. Now It Is Neoliberal Violence.
This distorted idea has emerged at the intersection between neoliberalism and fascism, says scholar Angela Mitropoulos.
Trump Blocks FDA on Stricter COVID-19 Vaccine Standards
Following the FDA recommendations would all but preclude any emergency clearance for a vaccine before Election Day.
It’s Highly Unlikely That We Will Have a Safe Vaccine by Election Time
Even if Pfizer’s vaccine trial yields results by November 3, the FDA review would still take weeks to complete.
Trump’s Vaccine Czar Refuses to Divest From Company Developing COVID Vaccine
Moncef Slaoui owns $10 million in stock of a company working with his team to develop a vaccine.